Provided by Tiger Trade Technology Pte. Ltd.

CG Oncology Inc.

78.23
-1.5800-1.98%
Post-market: 78.230.00000.00%16:53 EDT
Volume:1.16M
Turnover:91.22M
Market Cap:6.93B
PE:-28.72
High:79.89
Open:79.44
Low:77.51
Close:79.81
52wk High:80.97
52wk Low:25.25
Shares:88.64M
Float Shares:64.73M
Volume Ratio:1.56
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7235
EPS(LYR):-2.0826
ROE:-26.41%
ROA:-17.67%
PB:6.74
PE(LYR):-37.56

Loading ...

CG Oncology price target lowered to $83 from $84 at BofA

TIPRANKS
·
May 10

Analyst Reiterates Buy on CG Oncology, Maintains $90 Price Target Ahead of Key Cretostimogene Data Readouts

TIPRANKS
·
May 10

Alec Stranahan Reiterates Buy on CG Oncology, Maintains $83 Price Target on Cretostimogene’s Best-in-Class Potential and Upcoming PIVOT-006 Catalyst

TIPRANKS
·
May 10

Analysts Are Bullish on These Healthcare Stocks: Zevra Therapeutics (ZVRA), CG Oncology, Inc. (CGON)

TIPRANKS
·
May 09

CG Oncology reports Q1 EPS (71c), consensus (54c)

TIPRANKS
·
May 09

CG Oncology Inc expected to post a loss of 61 cents a share - Earnings Preview

Reuters
·
May 09

CG Oncology Q1 Net Loss Widens, Revenue Rises

MT Newswires Live
·
May 08

CG Oncology Q1 EPS $(0.71) Misses $(0.57) Estimate, Sales $1.083M Beat $493.182K Estimate

Benzinga Earnings
·
May 08

Earnings Flash (CGON) CG Oncology Posts Q1 Net Loss $0.71 a Share, vs. FactSet Est of $0.54 Loss

MT Newswires Live
·
May 08

CG Oncology Inc - Q1 2026 Net Loss$0.71 per Share

THOMSON REUTERS
·
May 08

Press Release: CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
May 08

CG Oncology to Present at Upcoming Investor Conferences in May

GlobeNewswire
·
May 05

Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), CG Oncology, Inc. (CGON) and Icon (ICLR)

TIPRANKS
·
Apr 29

CG Oncology Pivot-006 Data in Early June Seen as 'Complex' Catalyst, RBC Says

MT Newswires Live
·
Apr 28

CG Oncology Is Maintained at Outperform by RBC Capital

Dow Jones
·
Apr 27

RBC Raises Price Target on CG Oncology to $79 From $73, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Apr 27

CG Oncology price target raised to $79 from $73 at RBC Capital

TIPRANKS
·
Apr 27

Analysts Have Conflicting Sentiments on These Healthcare Companies: Chemed (CHE), Bausch Health Companies (BHC) and CG Oncology, Inc. (CGON)

TIPRANKS
·
Apr 27

CG Oncology announces annual shareholder meeting

Reuters
·
Apr 25

Analysts Offer Insights on Healthcare Companies: Monopar Therapeutics Inc (MNPR), ClearPoint Neuro (CLPT) and CG Oncology, Inc. (CGON)

TIPRANKS
·
Apr 21